Global Huber Needles Market Size, Share, Trend and Growth Report 2030

It is projected that the size of the global Huber needle market would increase to around USD 78 million by 2030 with a compound annual growth rate (CAGR) of approximately 6.15% between 2023 and 2030. In 2022, the market was estimated to be worth approximately USD 48 million.

Huber Needle Market: Overview

Huber needles are needles that are used in a variety of medical operations. They are medical equipment. They have been utilized in particular for procedures that require venous access for an extended period of time. Along with additional factors like infusing nutrients or blood products into a patient’s system over a period of time encompassing weeks, months, or even years, this method is utilized for delivering medication or collecting blood from a patient. It can also be used to draw blood.

As a result of its widespread application in the process of accessing implanted vascular access devices (VADs), also known as peripherally inserted catheters, tunnel catheters, and implantable ports, Huber needles have risen to a higher level of prominence in the medical world, where they are regarded as primary and essential devices. Medical practitioners have long-term access to a patient’s bloodstream through the use of VADs, which enables them to regularly administer medications such as intravenous (IV) antibiotics. VADs also allow patients to receive blood transfusions. Huber needles are non-coring right-angle needles, and it is anticipated that the market for these types of medical devices would expand at a rate that is consistent.

Huber Needle Market: Growth Drivers

The increasing frequency of chemotherapy treatments is expected to be the primary driver of market expansion.

As a result of an increase in the number of people being treated for cancer all over the world and an increase in the frequency of chemotherapy sessions, it is anticipated that the market for Huber needles would expand. Because of the unique construction of Huber needles, these kinds of medical treatments require their use alongside chemotherapy ports. Because the needle is quite long and the tip is beveled, it is able to easily penetrate the skin as well as the silicone septum which is a component of the reservoir of the implanted port.

Huber Needle Market: Segmentation

The global market for Huber needles may be broken down into distinct submarkets defined by factors such as application, product type, end-user, and geographic location.

The global market for lap-band modifications, dialysis, IV cancer application, home parenteral nutrition, blood transfusions, and other applications has been broken down into its respective submarkets. The largest increase was seen in the intravenous cancer application market, which is a category in which these needles are utilized extensively for intravenous therapies and chemotherapy treatments connected to cancer.

Huber Needle Market: Regional Analysis

During the anticipated time frame, North America is expected to maintain its growth trajectory.

During the duration of the forecast, it is anticipated that the market for Huber needles will be driven by North America. This is due to the presence of a solid medical infrastructure in the region, in addition to the fact that the United States is one of the most notable nations in terms of the treatment of severe kinds of cancer. As of the year 2022, the country had recorded roughly 18.05 million people as having survived cancer.

In addition to this, the Food and Drug Administration in the United States has granted approval for the utilization of Huber needles during medical procedures, which has contributed to the increased use of these medical devices across the country.

Huber Needle Market: Competitive Analysis

The global Huber needle market is led by players like:

AngioDynamics Inc.
Becton
Dickinson and Company (BD)
B. Braun Melsungen AG
Nipro Medical Corporation
Smiths Medical
Medtronic plc
Baxter International Inc.
Orientmed International Holding Limited
Teleflex Incorporated
Cook Medical Inc.
Terumo Corporation
Infusion Setters Healthcare Inc.
Vygon Group
Argon Medical Devices Inc.
Amecath Medical Technologies
The global Huber needle market is segmented as follows:
By Application

Lap-Band Adjustments
Dialysis
IV Cancer Application
Home Parenteral Nutrition
Blood Transfusions
Others
By Product Type

Straight Huber Needles
Curved Huber Needles
By End-Users

Ambulatory Services
Hospitals & Clinics
Home Care Settings
Oncology Centers
Others
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa